Heart Failure Diagnosis, Treatment and Management

April 5, 2022

Cost: Free
Date: Tuesday, April 5, 2022; 1:00pm - 2:30pm ET

Heart Failure Diagnosis, Treatment and Management in Primary Care

Heart failure is the development of abnormal cardia function characterized by the heart's failure to pump blood adequately. Patients commonly seek care as a result of sudden shortness of breath, particularly after lying down to sleep (orthopnea), and excessive fatigue. Heart failure incidence and prevalence increases strikingly with age, making it the most common reason for hospitalization among older adults. To a large extent, heart failure is a geriatric syndrome similar to dementia, falls and frailty. Rehospitalization and mortality rates remain high despite improvements in outcomes for older adults with heart failure.

As of 2017, heart failure affected an estimated 6.5 million Americans 20 years of age and older, according to the American Heart Association. In spite of a decrease in incidence from 2000-2012, heart failure deaths are currently on the rise again, according to 2012-2014 data released by the Centers for Disease Control and Prevention. In the United States, approximately 309,000 deaths are attributable to heart failure and 960,000 new diagnosis are made each year. U.S. heart failure costs exceeds $30 billion in 2013 and are projected to increase upwards of $69.8 by 2030.

Death by heart failure is preventable when it is recognized early and managed effectively. Because most heart failure patients are diagnosed by their primary care clinician, clinicians must be able to recognize the highly variable clinical features of heart failure and must respond with appropriate therapies or specialist referrals. Because new knowledge about heart failure is accumulating quickly, primary care clinicians must stay up-to-date to adequately implement effective strategies of care for heart failure patients.

This course will provide primary care clinicians with education to support earlier diagnosis of heart failure, establish a treatment plan and monitor disease progression in order to improve patient outcomes and reduce disease burden.

Target Audience

This education program is geared to members of interdisciplinary health care teams working in a primary care setting, including:

  • Nurses
  • Pharmacists
  • Physicians
  • and Others

Learning Objectives

After successful completion of this activity, learners will be able to:

  • Quantify the health and economic impact of heart failure at the national level.
  • Discuss screening and diagnosis guidelines for heart failure, as well as its risk factors and symptoms.
  • Comprehend heart failure treatment guidelines, differentiate between pharmacological and nonpharmacological treatment options and identify the appropriate course of treatment based on patient presentation.
  • Recognize and reduce barriers to specialist referral and care coordination.

This course was developed through an Independent Medical Education Grant from Merck.

Course summary
Available credit: 
  • 1.50 ACPE
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 IPCE
  • 1.00 Participation
  • 2.00 PCMH CCE
Course opens: 
01/27/2022
Course expires: 
04/12/2023
Event starts: 
04/05/2022 - 1:00pm EDT
Event ends: 
04/05/2022 - 2:30pm EDT

Stephen J. Greene, MD, FACC

Dr. Greene is a heart failure cardiologist and Assistant Professor of Medicine in the Division of Cardiology and Duke Clinical Research Institute, at the Duke University School of Medicine. Dr. Greene’s research focuses on improving quality of care and outcomes for patients with heart failure.  He has been a co-investigator and co-author of multiple national and international heart failure trials studying medical therapies for heart failure, including the ASTRONAUT, SOCRATES-Reduced, and COMPOSE trials, as well as the ongoing TRANSFORM-HF trial. He has also led multiple analyses from national registries characterizing the quality of heart failure care in U.S. clinical practice, including studies leveraging the American Heart Association’s Get With The Guidelines Heart Failure registry, the VICTORIA registry, and the CHAMP-HF registry.  Dr. Greene’s collaborative work has led to more than 225 publications in peer-reviewed journals. 

 

Ravi B. Patel, MD, MSc

Dr. Ravi Patel is an Assistant Professor of Medicine (Cardiology) and Preventive Medicine at Northwestern University Feinberg School of Medicine. Dr. Patel earned his MD from Northwestern University Feinberg School of Medicine, completed his Internal Medicine residency at Brigham and Women’s Hospital/Harvard Medical School, and cardiology fellowship at Northwestern University. His research aims to understand the common pathogenesis of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF), which represent 2 highly prevalent cardiovascular syndromes of aging. Dr. Patel has also served as the site principal investigator for several multicenter clinical trials of HFpEF.

image

In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team. 

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change. 

This educational activity is approved for: 1.5 AMA PRA Category 1 CreditTM and ACPE.

This educational activity is approved for 1.5 nursing contact hours.*

The assigned universal program number: JA0004597-0000-22-002-04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.

This live course grants 2.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.  

* Please note – You must attend the entire program to be eligible for total number of contact hours.

This course was developed through an Independent Medical Education Grant from Merck.

 

Disclosure of Relevant Financial Relationships

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations:

Faculty:
Ravi Patel: None

Additional Planning Committee Members:
Zach Baldwin: None
Eric Schneider: None
Tracelyn Thigpen: None
Ashley Turner: None

                               Affiliation/Financial Interest                               Name of Organization

Stephen Greene    Grant/Research Support                                        American Heart Association, NHLBI, Amgen, AstraZeneca, Bristol Meyers Squibb, Merck, Novartis, Pfizer, Sanofi
                               Consultant                                                             Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Cytokinetics, Merck, Vifor

Program content was peer reviewed to ensure that it is fair-balanced and free from commercial bias.

This program was developed in part by NCQA staff.

Available Credit

  • 1.50 ACPE
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 IPCE
  • 1.00 Participation
  • 2.00 PCMH CCE
Please login or register to take this course.

Required Hardware/software

We recommend using either Google Chrome or Mozilla Firefox as your browser for the optimal experience with the NCQA Education learning management system.